We are live on ! Find out more
MCK icon

McKesson

938.84 USD
+8.59
0.92%
At close Updated Oct 9, 4:00 PM EDT
Pre-market
After hours
938.84
0.00
0%
1 day
0.92%
5 days
3.71%
1 month
5.29%
3 months
18.42%
6 months
7.49%
Year to date
14.01%
1 year
23.86%
5 years
365.28%
10 years
467.86%
 

About: McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.

Employees: 43,000

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 62.8%
Neutral 29.5%
Negative 7.7%
Positive
Zacks Investment Research
2 days ago
Why McKesson (MCK) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why McKesson (MCK) is a Top Momentum Stock for the Long-Term
Positive
Zacks Investment Research
3 days ago
Here's Why McKesson (MCK) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why McKesson (MCK) is a Strong Growth Stock
Positive
Zacks Investment Research
3 days ago
Is McKesson (MCK) Outperforming Other Medical Stocks This Year?
Here is how McKesson (MCK) and Avantor, Inc. (AVTR) have performed compared to their sector so far this year.
Is McKesson (MCK) Outperforming Other Medical Stocks This Year?
Neutral
Zacks Investment Research
3 days ago
Is It Worth Investing in McKesson (MCK) Based on Wall Street's Bullish Views?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Is It Worth Investing in McKesson (MCK) Based on Wall Street's Bullish Views?
Negative
Zacks Investment Research
4 days ago
Here's Why McKesson (MCK) Fell More Than Broader Market
In the closing of the recent trading day, McKesson (MCK) stood at $910.33, denoting a -1.23% move from the preceding trading day.
Here's Why McKesson (MCK) Fell More Than Broader Market
Positive
Zacks Investment Research
4 days ago
Is McKesson (MCK) a Solid Growth Stock? 3 Reasons to Think "Yes"
McKesson (MCK) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Is McKesson (MCK) a Solid Growth Stock? 3 Reasons to Think "Yes"
Positive
Zacks Investment Research
4 days ago
Is Most-Watched Stock McKesson Corporation (MCK) Worth Betting on Now?
McKesson (MCK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Is Most-Watched Stock McKesson Corporation (MCK) Worth Betting on Now?
Positive
Benzinga
5 days ago
Option Care Stock Trades Below McKesson's Deal Price — Here's the Spread
Option Care Health Inc. (NASDAQ:OPCH) agreed Tuesday to be taken private by Clayton Dubilier & Rice and McKesson Corp. (NYSE:MCK) for $32.05 a share in cash. The deal gives the home-infusion provider a total enterprise value of about $5.8 billion.
Option Care Stock Trades Below McKesson's Deal Price — Here's the Spread
Positive
Investors Business Daily
5 days ago
Option Health Care Skyrockets On $5.8 Billion McKesson, CD&R Takeover
Option Health Care shares skyrocketed Tuesday after McKesson and CD&R agreed to buy the infusion services company for $5.8 billion.
Option Health Care Skyrockets On $5.8 Billion McKesson, CD&R Takeover
Positive
Benzinga
5 days ago
McKesson Takes A Stake In Option Care — With An Option On The Rest
Private equity firm CD&R and McKesson Corporation (NYSE:MCK) on Tuesday agreed to acquire Option Care Health Inc. (NASDAQ:OPCH) for $32.05 per share.
McKesson Takes A Stake In Option Care — With An Option On The Rest
Price charts implemented using Lightweight Charts™